Loading people...
Casper de Clercq is a General Partner at Norwest Venture Partners in Palo Alto, California, where he co-leads the firm's healthcare practice and deploys capital from the firm's $3 billion Fund XVI. Leveraging over 30 years of operational and investment experience, he targets mid-to-late-stage companies across digital health, medical devices, diagnostics, and technology-enabled services. He has successfully led investments or held board seats at prominent enterprises including Teladoc, iRhythm Technologies, Omada Health, and Ilypsa prior to its acquisition by Amgen. Previously, he served as a Partner at U.S. Venture Partners from 2004 to 2011 and co-founded Epicor Medical, acting as Vice President from 1999 to 2003. His early career included strategy consulting at Bain & Company, and he holds an MBA from the Stanford University Graduate School of Business and a BA from Dartmouth College.
Casper de Clercq stands as a prominent General Partner at Norwest Venture Partners, a leading multi-stage investment firm. At Norwest, Casper is a driving force behind the firm's healthcare investment strategy, focusing on companies poised to revolutionize the healthcare industry through technology and innovation. His expertise is particularly concentrated in areas such as healthcare IT, digital health, medical devices, diagnostics, and healthcare services.
Casper de Clercq's investment philosophy is deeply rooted in his extensive operational background within the healthcare sector. He seeks out visionary entrepreneurs and disruptive technologies that promise to enhance efficiency, reduce costs, and ultimately improve patient care. His portfolio reflects a commitment to companies that are not only financially promising but also have a significant positive impact on the healthcare ecosystem. He is known for his hands-on approach, working closely with founders and management teams to scale their businesses and navigate the complexities of the healthcare market.
Before joining Norwest Venture Partners, Casper de Clercq built an impressive career as an entrepreneur and executive. He co-founded and served as CEO of two successful venture-backed companies: TherOx, a medical device company acquired by ZOLL Medical, and Image Guided Neurologics, which was acquired by Medtronic. These experiences provided him with invaluable insights into the challenges and opportunities inherent in building and growing healthcare technology companies from the ground up. Earlier in his career, he held significant leadership roles at Guidant Corporation, a global leader in medical technology, which was later acquired by Boston Scientific and Abbott Laboratories. This rich operational history gives him a unique perspective as an investor, allowing him to truly understand the entrepreneurial journey.
Among his notable investments, Casper de Clercq has supported companies that have made significant strides in their respective fields. These include Qventus, a real-time operations management platform for healthcare; TigerConnect, a leading clinical communication and collaboration solution; iRhythm Technologies, a digital healthcare company providing an innovative cardiac monitoring service; Omada Health, a pioneer in digital care programs for chronic conditions; and Virta Health, which offers a science-backed approach to reverse type 2 diabetes. His track record underscores his ability to identify and nurture companies that achieve both commercial success and meaningful healthcare impact.
Casper de Clercq is a General Partner at Norwest Venture Partners, a leading multi-stage investment firm. He specializes in healthcare investments, leveraging his extensive background as an entrepreneur and executive in the healthcare technology sector.
Casper de Clercq primarily invests in transformative healthcare companies. His focus areas include healthcare IT, digital health, medical devices, diagnostics, and healthcare services, seeking innovations that improve patient care and healthcare delivery.
Casper de Clercq works as a General Partner at Norwest Venture Partners. Norwest Venture Partners is a prominent venture capital and growth equity investment firm.
